- Home
- ACIU vs MDV Comparison
ACIU vs MDV Comparison
Compare ACIU & MDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- MDV
- Stock Information
- Founded
- ACIU 2003
- MDV 2015
- Country
- ACIU Switzerland
- MDV United States
- Employees
- ACIU N/A
- MDV N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- MDV Transportation Services
- Sector
- ACIU Health Care
- MDV Consumer Discretionary
- Exchange
- ACIU Nasdaq
- MDV Nasdaq
- Market Cap
- ACIU 168.7M
- MDV 149.1M
- IPO Year
- ACIU 2016
- MDV 2022
- Fundamental
- Price
- ACIU $2.07
- MDV $14.10
- Analyst Decision
- ACIU Strong Buy
- MDV
- Analyst Count
- ACIU 1
- MDV 0
- Target Price
- ACIU $12.00
- MDV N/A
- AVG Volume (30 Days)
- ACIU 119.1K
- MDV 44.8K
- Earning Date
- ACIU 08-05-2025
- MDV 08-05-2025
- Dividend Yield
- ACIU N/A
- MDV 8.30%
- EPS Growth
- ACIU N/A
- MDV N/A
- EPS
- ACIU N/A
- MDV N/A
- Revenue
- ACIU $32,014,254.00
- MDV $46,738,000.00
- Revenue This Year
- ACIU N/A
- MDV $2.21
- Revenue Next Year
- ACIU $533.21
- MDV $4.45
- P/E Ratio
- ACIU N/A
- MDV N/A
- Revenue Growth
- ACIU 91.20
- MDV N/A
- 52 Week Low
- ACIU $1.43
- MDV $13.62
- 52 Week High
- ACIU $4.37
- MDV $18.11
- Technical
- Relative Strength Index (RSI)
- ACIU 59.88
- MDV 42.25
- Support Level
- ACIU $1.79
- MDV $14.01
- Resistance Level
- ACIU $2.10
- MDV $14.73
- Average True Range (ATR)
- ACIU 0.17
- MDV 0.32
- MACD
- ACIU 0.00
- MDV 0.03
- Stochastic Oscillator
- ACIU 71.93
- MDV 9.68
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About MDV Modiv Industrial Inc. Class C
Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.